# The Availability and Safety Study of Remimazolam Besylate for Injection on Sedation of ERAS Patients

> **NCT04947345** · PHASE3 · UNKNOWN · sponsor: **Peking Union Medical College Hospital** · enrollment: 84 (estimated)

## Conditions studied

- Analgesia
- Postoperative Pain

## Interventions

- **DRUG:** Remimazolam Besylate
- **DRUG:** Propofol

## Key facts

- **NCT ID:** NCT04947345
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-09-01
- **Primary completion:** 2022-03-01
- **Final completion:** 2022-09-01
- **Target enrollment:** 84 (ESTIMATED)
- **Last updated:** 2021-07-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04947345

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04947345, "The Availability and Safety Study of Remimazolam Besylate for Injection on Sedation of ERAS Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04947345. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*